Present trends in the encapsulation of anticancer drugs

Author:

Montané Xavier1ORCID,Matulewicz Karolina2,Balik Karolina2,Modrakowska Paulina2,Łuczak Marcin3,Pérez Pacheco Yaride4,Reig-Vano Belen4,Montornés Josep M.5,Bajek Anna2,Tylkowski Bartosz5

Affiliation:

1. Departament de Química Analítica i Química Orgànica , Universitat Rovira i Virgili Facultat de Quimica , Carrer Marcel·lí Domingo s/n, 43007, Tarragona , Spain

2. Department of Tissue Engineering Chair of Urology , Nicolaus Copernicus University in Toruń Ludwik Rydygier Collegium Medicum in Bydgoszcz , Karlowicza St. 24, 85-092, Bydgoszcz , Poland

3. Wrzesińskiego Pułku Piechoty we Wrześni , Samorządowa Szkoła Podstawowa nr 1 im. 68 , 62-300, Września , Poland

4. Departament d’Enginyeria Química , Universitat Rovira i Virgili Escola Tècnica Superior d’Enginyeria Química , Av. Països Catalans, 26, 43007, Tarragona , Spain

5. Chemical Unit , Eurecat Centre Tecnològic de Catalunya , Carrer Marcel·lí Domingo, s/n,43007, Tarragona , Spain

Abstract

Abstract Different nanomedicine devices that were developed during the recent years can be suitable candidates for their application in the treatment of various deadly diseases such as cancer. From all the explored devices, the nanoencapsulation of several anticancer medicines is a very promising approach to overcome some drawbacks of traditional medicines: administered dose of the drugs, drug toxicity, low solubility of drugs, uncontrolled drug delivery, resistance offered by the physiological barriers in the body to drugs, among others. In this chapter, the most important and recent progress in the encapsulation of anticancer medicines is examined: methods of preparation of distinct nanoparticles (inorganic nanoparticles, dendrimers, biopolymeric nanoparticles, polymeric micelles, liposomes, polymersomes, carbon nanotubes, quantum dots, and hybrid nanoparticles), drug loading and drug release mechanisms. Furthermore, the possible applications in cancer prevention, diagnosis, and cancer therapy of some of these nanoparticles have been highlighted.

Publisher

Walter de Gruyter GmbH

Subject

General Physics and Astronomy,General Materials Science,General Chemistry

Reference76 articles.

1. Moderna’s. Moderna work on a COVID-19 vaccine candidate. Available from: https://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19 [Accessed 14 Aug 2020].

2. Shewach, DS, Kuchta, RD. Introduction to cancer chemotherapeutics. Chem Rev 2009;109:2859–61, https://doi.org/10.1021/cr900208x.

3. Costa, J. Cancer. Availabe from: https://www.britannica.com/science/cancer-disease [Accessed 02 Jan 2020].

4. Blackadar, CB. Historical review of the causes of cancer. World J Clin Oncol 2016;7:54–86, https://doi.org/10.5306/wjco.v7.i1.54.

5. Afshar, M, Madani, S, Tarazoj, AA, Papi, SH, Otroshi, O, Gandomani, HS, et al.. Physical activity and types of cancer. WCR 2018;5:1–11.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3